Advisory Committee; Change of Name and Function; Technical Amendment, 53816-53817 [2011-22105]

Download as PDF 53816 Federal Register / Vol. 76, No. 168 / Tuesday, August 30, 2011 / Rules and Regulations the 2011–12 crop year; (3) handlers are aware of this action which was unanimously recommended by the Committee at a public meeting and is similar to other assessment rate actions issued in past years; and (4) this interim rule provides a 60-day comment period, and all comments timely received will be considered prior to finalization of this rule. List of Subjects in 7 CFR Part 993 Marketing agreements, Plums, Prunes, Reporting and recordkeeping requirements. For the reasons set forth in the preamble, 7 CFR part 993 is amended as follows: PART 993—DRIED PRUNES PRODUCED IN CALIFORNIA 1. The authority citation for 7 CFR part 993 continues to read as follows: ■ Authority: 7 U.S.C. 601–674. 2. Section 993.347 is revised to read as follows: ■ § 993.347 Assessment rate. On and after August 1, 2011, an assessment rate of $0.22 per ton is established for California dried prunes. Dated: August 19, 2011. David R. Shipman, Acting Administrator, Agricultural Marketing Service. [FR Doc. 2011–22119 Filed 8–29–11; 8:45 am] BILLING CODE 3410–02–P and Vegetable Programs, AMS, USDA, P.O. Box 831, Beavercreek, Oregon 97004; telephone: (503) 632–8848; facsimile (503) 632–8852; or electronic mail: Maureen.Pello@ams.usda.gov. SUPPLEMENTARY INFORMATION: Background This rule establishes a Softwood Lumber Research, Promotion, Consumer Education and Industry Information Order (Order). The purpose of the Order is to strengthen the position of softwood lumber in the marketplace, maintain and expand markets for softwood lumber, and develop new uses for softwood lumber within the United States. The Order is issued pursuant to the Commodity Promotion, Research, and Information Act of 1996 (7 U.S.C. 7411–7425). Corrections In FR Doc. 2011–19491, published August 2, 2011 (76 FR 46185), make the following corrections. 1. On page 46193, in column 2, the words of issuance are corrected to read as follows: For the reasons set forth in the preamble, Title 7, Chapter XI of the Code of Federal Regulations is amended by adding subpart A to part 1217 to read as follows: 2. On page 46194, column 1, the words ‘‘Subpart B—[Reserved]’’ are removed. 3. On page 46202 in column 1, § 1217.88 is revised to read as follows: § 1217.88 OMB Control numbers. The control numbers assigned to the information collection requirements by the Office of Management and Budget pursuant to the Paperwork Reduction Act of 1995, 44 U.S.C. Chapter 35, are OMB control number 0505–0001 (Board nominee background statement) and OMB control number 0581–0264. DEPARTMENT OF AGRICULTURE Agricultural Marketing Service 7 CFR Part 1217 [Document Number AMS–FV–10–0015C; FR] RIN 0581–AD03 Softwood Lumber Research, Promotion, Consumer Education and Industry Information Order; Correction Agricultural Marketing Service. ACTION: Corrections to final rule. Dated: August 22, 2011. David R. Shipman, Acting Administrator. [FR Doc. 2011–22150 Filed 8–29–11; 8:45 am] BILLING CODE 3410–02–P AGENCY: This document contains corrections to the final rule published on August 2, 2011 (76 FR 46185), regarding softwood lumber. Corrections are made in the amendatory instruction section and in § 1217.88 of the final rule. srobinson on DSK4SPTVN1PROD with RULES SUMMARY: Effective Date: August 31, 2011. FOR FURTHER INFORMATION CONTACT: Maureen T. Pello, Marketing Specialist, Research and Promotion Division, Fruit DATES: VerDate Mar<15>2010 18:46 Aug 29, 2011 Jkt 223001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 14 [Docket No. FDA–2011–N–0002] Advisory Committee; Change of Name and Function; Technical Amendment AGENCY: Food and Drug Administration, HHS. PO 00000 Frm 00006 Fmt 4700 Sfmt 4700 ACTION: Final rule. The Food and Drug Administration (FDA) is amending the standing advisory committees’ regulations to change the name and function of the Anesthetic and Life Support Drugs Advisory Committee. This action is being taken to reflect changes made to the charter for this advisory committee. DATES: Effective September 6, 2011. FOR FURTHER INFORMATION CONTACT: Philip Bautista, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 31, Rm. 2417, Silver Spring, MD 20993–0002, 301– 796–9001. SUPPLEMENTARY INFORMATION: FDA is announcing that the name of the Anesthetic and Life Support Drugs Advisory Committee, which was established on May 1, 1978, has been changed. The Agency decided that the name ‘‘Anesthetic and Analgesic Drug Products Advisory Committee’’ would more accurately describe the subject areas for which the committee is responsible. The mandate of the committee is being expanded to include analgesics, e.g., abuse-deterrent opioids, novel analgesics, and opioid abuse. The Committee reviews and evaluates available data concerning the safety and effectiveness of marketed and investigational human drug products including analgesics, e.g., abusedeterrent opioids, novel analgesics, and issues related to opioid abuse, and those for use in anesthesiology. The Anesthetic and Life Support Drugs Advisory Committee name was changed and its functions expanded in the charter renewal dated June 9, 2011. FDA is hereby revising 21 CFR 14.100 (c)(1) to reflect these changes. Publication of this final rule constitutes a final action on this change under the Administrative Procedure Act. Under 5 U.S.C. 553(b)(3)(B) and (d) and 21 CFR 10.40(d) and (e), the Agency finds good cause to dispense with notice and public procedure and to proceed to an immediately effective regulation. Such notice and procedures are unnecessary and are not in the public interest, because the final rule is merely codifying the new name and the expanded function of the advisory committee to reflect the current committee charter. SUMMARY: List of Subjects in 21 CFR Part 14 Administrative practice and procedure, Advisory committees, Color additives, Drugs, Radiation protection. Therefore, under the Federal Food and Drug, and Cosmetic Act and under E:\FR\FM\30AUR1.SGM 30AUR1 Federal Register / Vol. 76, No. 168 / Tuesday, August 30, 2011 / Rules and Regulations authority delegated to the Commissioner of Food and Drugs, 21 CFR part 14 is amended as follows: PART 14—PUBLIC HEARING BEFORE A PUBLIC ADVISORY COMMITTEE 1. The authority citation for 21 CFR part 14 continues to read as follows: ■ Authority: 5 U.S.C. App. 2; 15 U.S.C. 1451–1461; 21 U.S.C. 41–50, 141–149, 321– 394, 467f, 679, 821, 1034; 28 U.S.C. 2112; 42 U.S.C. 201, 262, 263b, 264; Pub. L. 107–109, Pub. L. 108–155. 2. Section 14.100 is amended by revising the heading of paragraph (c)(1) and paragraph (c)(1)(ii) to read as follows: ■ § 14.100 List of standing advisory committees. * * * * * (c) * * * (1) Anesthetic and Analgesic Drug Products Advisory Committee. * * * * * (ii) Function: Reviews and evaluates data concerning the safety and effectiveness of marketed and investigational human drug products including analgesics, e.g., abusedeterrent opioids, novel analgesics, and issues related to opioid abuse, and those for use in anesthesiology. * * * * * Dated: August 25, 2011. Jill Hartzler Warner, Acting Associate Commissioner for Special Medical Programs. [FR Doc. 2011–22105 Filed 8–29–11; 8:45 am] BILLING CODE 4160–01–P allow the Commission time to convene a Tribal Advisory Committee (TAC), to receive and review input from the TAC, and to thoroughly review comments from the public on any potential amendments to the regulations. DATES: This rule is effective October 12, 2012. The effective date for the amendments to §§ 542.7 and 542.16 in the final rule published October 10, 2008 (73 FR 60492), delayed October 9, 2009 (74 FR 52138) and September 10, 2010 (75 FR 55269), is further delayed until October 12, 2012. Comments must be received on or before October 25, 2011. You may submit comments by any one of the following methods, however, please note that comments sent by electronic mail are strongly encouraged. • E-mail comments to: reg.review@nigc.gov. • Mail comments to: Lael Echo-Hawk, Counselor to the Chair, National Indian Gaming Commission, 1441 L Street, NW., Suite 9100, Washington, DC 20005. • Hand deliver comments to: 1441 L Street, NW., Suite 9100, Washington, DC 20005. • Fax comments to: Lael Echo-Hawk, Counselor to the Chair, National Indian Gaming Commission at 202–632–0045. FOR FURTHER INFORMATION CONTACT: Lael Echo-Hawk, National Indian Gaming Commission, 1441 L Street, NW., Suite 9100, Washington, DC 20005. Telephone: 202–632–7009; e-mail: reg.review@nigc.gov. ADDRESSES: The Indian Gaming Regulatory Act (IGRA or Act), Public Law 100–497, 25 U.S.C. 2701 et seq., was signed into law on October 17, 1988. The Act establishes the National Indian Gaming Commission (‘‘Commission’’) and sets out a comprehensive framework for the regulation of gaming on Indian lands. The NIGC issued a final rule that superseded specified sections of established Minimum Internal Control Standards and replaced them with a new part titled Minimum Internal Control Standards Class II Gaming, that was published in the Federal Register on October 10, 2008 (73 FR 60492). The final rule provided an effective date for amendments to §§ 542.7 and 542.16 of October 13, 2009. An extension delayed the effective date of the amendments until October 13, 2010. 74 FR 52138, October 9, 2009. An additional extension delayed the effective date of the amendments until October 13, 2011, 75 FR 55269, September 10, 2010. The NIGC is again extending the effective SUPPLEMENTARY INFORMATION: DEPARTMENT OF THE INTERIOR National Indian Gaming Commission 25 CFR Parts 542 and 543 Minimum Internal Control Standards for Class II Gaming National Indian Gaming Commission, Interior. ACTION: Final rule; delay of effective date and request for comments. AGENCY: The National Indian Gaming Commission (‘‘NIGC’’) announces the delay of the effective date on the final rule for Minimum Internal Control Standards for Class II Gaming. The final rule was first published in the Federal Register on October 10, 2008. The Commission delayed the effective date for portions of the final rule on October 9, 2009, and September 10, 2010. With this document, the Commission further delays the effective date in order to srobinson on DSK4SPTVN1PROD with RULES SUMMARY: VerDate Mar<15>2010 18:46 Aug 29, 2011 Jkt 223001 PO 00000 Frm 00007 Fmt 4700 Sfmt 4700 53817 date of these amendments to October 12, 2012. The rule at § 543.3(c)(3) also set a deadline of within six months of the date the tribal gaming regulatory authorities’ enactment of tribal internal controls for tribal operators to come into compliance with tribal internal controls. This deadline has likewise been extended to October 12, 2012. As explained in the preamble to the final rule (73 FR 60492 (October 10, 2008)), the Commission intended these amendments to be the first part of a multi-phase process of establishing separate MICS for class II gaming and that the extended effective date would provide the necessary time to complete this process. On October 9, 2009, the Commission extended the effective date of the amendments until October 13, 2010, anticipating that all phases of the process would then be complete and that a final comprehensive set of class II MICS would take effect at that time. 74 FR 52138 (October 9, 2009). The newly appointed Commission approved an additional extension to delay the effective date of the amendments until October 13, 2011, 75 FR 55269 (September 10, 2010). The Commission then decided to create a Tribal Advisory Committee to assist in the review of these rules. The NIGC is again extending the effective date of these amendments to October 12, 2012 to allow time for the transition as contemplated by the final rule. List of Subjects 25 CFR Part 542 Accounting, Gambling, Indians— lands, Reporting and recordkeeping requirements. 25 CFR Part 543 Administrative practice and procedure, Gambling, Indians—lands, Reporting and recordkeeping requirements. For the reasons set forth above, under the authority at 25 U.S.C. 2701, 2702, 2706, et seq., the effective date for the amendments to §§ 542.7 and 542.16 in the final rule published October 10, 2008, 73 FR 60492, is delayed from October 13, 2011, until October 12, 2012 and 25 CFR part 543.3 is amended as set forth below: PART 543—MINIMUM INTERNAL CONTROL STANDARDS FOR CLASS II GAMING 1. The authority citation for part 543 continues to read as follows: ■ Authority: 25 U.S.C. 2701 et seq. E:\FR\FM\30AUR1.SGM 30AUR1

Agencies

[Federal Register Volume 76, Number 168 (Tuesday, August 30, 2011)]
[Rules and Regulations]
[Pages 53816-53817]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-22105]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 14

[Docket No. FDA-2011-N-0002]


Advisory Committee; Change of Name and Function; Technical 
Amendment

AGENCY: Food and Drug Administration, HHS.

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is amending the 
standing advisory committees' regulations to change the name and 
function of the Anesthetic and Life Support Drugs Advisory Committee. 
This action is being taken to reflect changes made to the charter for 
this advisory committee.

DATES: Effective September 6, 2011.

FOR FURTHER INFORMATION CONTACT: Philip Bautista, Center for Drug 
Evaluation and Research, Food and Drug Administration, 10903 New 
Hampshire Ave., Bldg. 31, Rm. 2417, Silver Spring, MD 20993-0002, 301-
796-9001.

SUPPLEMENTARY INFORMATION: FDA is announcing that the name of the 
Anesthetic and Life Support Drugs Advisory Committee, which was 
established on May 1, 1978, has been changed. The Agency decided that 
the name ``Anesthetic and Analgesic Drug Products Advisory Committee'' 
would more accurately describe the subject areas for which the 
committee is responsible. The mandate of the committee is being 
expanded to include analgesics, e.g., abuse-deterrent opioids, novel 
analgesics, and opioid abuse.
    The Committee reviews and evaluates available data concerning the 
safety and effectiveness of marketed and investigational human drug 
products including analgesics, e.g., abuse-deterrent opioids, novel 
analgesics, and issues related to opioid abuse, and those for use in 
anesthesiology.
    The Anesthetic and Life Support Drugs Advisory Committee name was 
changed and its functions expanded in the charter renewal dated June 9, 
2011. FDA is hereby revising 21 CFR 14.100 (c)(1) to reflect these 
changes.
    Publication of this final rule constitutes a final action on this 
change under the Administrative Procedure Act. Under 5 U.S.C. 
553(b)(3)(B) and (d) and 21 CFR 10.40(d) and (e), the Agency finds good 
cause to dispense with notice and public procedure and to proceed to an 
immediately effective regulation. Such notice and procedures are 
unnecessary and are not in the public interest, because the final rule 
is merely codifying the new name and the expanded function of the 
advisory committee to reflect the current committee charter.

List of Subjects in 21 CFR Part 14

    Administrative practice and procedure, Advisory committees, Color 
additives, Drugs, Radiation protection.

    Therefore, under the Federal Food and Drug, and Cosmetic Act and 
under

[[Page 53817]]

authority delegated to the Commissioner of Food and Drugs, 21 CFR part 
14 is amended as follows:

PART 14--PUBLIC HEARING BEFORE A PUBLIC ADVISORY COMMITTEE

0
1. The authority citation for 21 CFR part 14 continues to read as 
follows:

    Authority: 5 U.S.C. App. 2; 15 U.S.C. 1451-1461; 21 U.S.C. 41-
50, 141-149, 321-394, 467f, 679, 821, 1034; 28 U.S.C. 2112; 42 
U.S.C. 201, 262, 263b, 264; Pub. L. 107-109, Pub. L. 108-155.


0
2. Section 14.100 is amended by revising the heading of paragraph 
(c)(1) and paragraph (c)(1)(ii) to read as follows:


Sec.  14.100  List of standing advisory committees.

* * * * *
    (c) * * *
    (1) Anesthetic and Analgesic Drug Products Advisory Committee.
* * * * *
    (ii) Function: Reviews and evaluates data concerning the safety and 
effectiveness of marketed and investigational human drug products 
including analgesics, e.g., abuse-deterrent opioids, novel analgesics, 
and issues related to opioid abuse, and those for use in 
anesthesiology.
* * * * *

    Dated: August 25, 2011.
Jill Hartzler Warner,
Acting Associate Commissioner for Special Medical Programs.
[FR Doc. 2011-22105 Filed 8-29-11; 8:45 am]
BILLING CODE 4160-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.